Target-organ damage in adolescent hypertension. Analysis of potential influencing factors, especially nitric oxide and endothelin-1

Journal of the Neurological Sciences

Volumn 247, Issue 2, 2006, Pages 138-143

  Katona, Éva ^a   Settakis, Georgios ^a   Varga, Zsuzsa ^a   Paragh, György ^a   Bereczki, Dániel ^a   Fülesdi, Béla ^a   Páll, Dénes ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Adolescent hypertension; Carotid intima media thickness; Endothelin; Left ventricular mass index; Nitric oxide

Indexed keywords

CHOLESTEROL; ENDOTHELIN 1; GLUCOSE; NITRIC OXIDE; TRIACYLGLYCEROL;

ADOLESCENT; ANTHROPOLOGY; ARTERY MEDIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INTIMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; ECHOCARDIOGRAPHY; ENDOTHELIN-1; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; NITRIC OXIDE; TRIGLYCERIDES; TUNICA INTIMA;

EID: 33748421119     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.04.007     Document Type: Article

References (43)

1. Anand N.K., and Tandon L. Prevalence of hypertension in schoolgoing children. Indian Pediatr 33 (1996) 377-381
2. Páll D., Katona É., Fülesdi B., Zrínyi M., Zatik J., Bereczki D., et al. Blood pressure distribution in a Hungarian adolescent population: comparison with normal values in the USA. J Hypertens 21 (2003) 41-47
3. Sianiko A.R., Gomez-Marin O., and Prineas R.J. Prevalence of "significant" hypertension in junior high school-aged children: the Children and adolescent Blood Pressure Program. J Pediatr 114 (1989) 664-669
4. Elisah M., Papanikolau N., Letzaris G., Dimoliatis J., and Siamopoulos K.C. Atherosclerotic risk factors in female students of northwestern Greece. J Hum Hypertens 7 (1993) 533-537
5. Grunberg H., and Thetloff M. The cardiovascular risk factor of Estonian school children. Acta Pediatr 87 (1998) 37-42
6. Flynn J.T. Hypertension in adolescents. Adolesc Med Clin 16 (2005) 11-29
7. Calderon K.S., Yucha C.B., and Schaffer S.D. Obesity-related cardiovascular risk factors: intervention recommendations to decrease adolescent obesity. J Pediatr Nurs 20 (2005) 3-14
8. Nelson M.J., Ragland D.R., and Syme S.L. Longitudinal prediction of adult blood pressure from juvenile blood pressure levels. Am J Epidemiol 136 (1992) 633-645
9. Berenson G.S., Srinivasan S.R., Bao W., Newman W.P., Tracy R.E., and Wattigney W.A. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338 (1998) 1650-1656
10. Berenson G.S., Srnivasan S.R., and Bogalusa Heart Study Group. Cardiovascular risk factors in youth with implications for aging: the Bogalusa Heart Study. Neurobiol Aging 26 (2005) 303-307
11. Páll D., Settakis G., Katona É., Csiba L., Kakuk G., Limburg M., et al. Increased common carotid artery intima media thickness in adolescent hypertension: results from the Debrecen Hypertension study. Cerebrovasc Dis 15 (2003) 167-172
12. Bots M.L., Dijk J.M., Oren A., and Grobbee D.E. Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens 20 (2002) 2317-2325
13. Vaudo G., Schilaci G., Evangelista F., Pasqualini L., Verdecchia P., and Mannarino E. Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension. Am J Hypertens 13 (2000) 324-331
14. Burke G.L., Evans G.W., Riley W.A., Sharrett A.R., Howard G., Barnes R.W., et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 26 (1995) 386-391
15. Cuspidi C., Mancia G., Ambrosioni E., Pessina A., Trimarco B., and Zanchetti A. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS). J Hum Hypertens 18 (2004) 891-896
16. Anderssen S.A., Hjelstuen A.K., Hjermann I., Bjerkan K., and Holme I. Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives. Atherosclerosis 178 (2005) 387-397
17. Gariepy J., Simon A., Chironi G., Moyse D., and Levenson J. Large artery wall thickening and its determinants under antihypertensive treatment: the IMT-INSIGHT study. J Hypertens 22 (2004) 137-143
18. Goddard J., and Webb D.J. Plasma endothelin concentrations in hypertension. J Cardiovasc Pharmacol 35 Suppl. 2 (2000) S25-S31
19. Goonasekera C.D., and Dillon M.J. Vascular endothelium and nitric oxide in childhood hypertension. Pediatr Nephrol 12 (1998) 676-689
20. Hare J.M. Nitroso-redox balance in the cardiovascular system. N Eng J Med 351 (2004) 2112-2114
21. Karvonen J., Kauma H., Kervinen K., Rantala M., Ikaheimo M., Paivansalo M., et al. Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 251 (2002) 102-110
22. Minami S., Yamano S., Yamamoto Y., Sasaki R., Nakashima T., Takaoka M., et al. Associations of plasma endothelin concentration with carotid atherosclerosis and asymptomatic cerebrovascular lesions in patients with essential hypertension. Hypertens Res 24 (2001) 663-670
23. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
24. Green L.C., Wagner D.A., Glogowsky J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and 15 N nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
25. Galli F., Varga Z., Balla J., Ferraro B., Canestrari F., Floridi A., et al. Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int 59 Suppl. 78 (2001) 148-154
26. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 31 (1988) 411-415
27. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
28. Alberts G.F., Peifley K.A., Johns A., Kleha J.F., and Winkles J.A. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J Biol Chem 269 (1994) 112-118
29. Rees D.D., Palmer R.M., and Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A 86 (1989) 3375-3378
30. Paniagua O.A., Bryant M.B., and Panza J.A. Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation 103 (2001) 1752-1758
31. Cardillo C., Kilcoyne C.M., Quyyumi A.A., Cannon III R.O., and Panza J.A. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 97 (1998) 851-856
32. Panza J.A. Endothelial dysfunction in essential hypertension. Clin Cardiol 20 11 Suppl. 2 (1997) II-26-II-33
33. Zinchuk V.V., Pronko T.P., and Lis M.A. Blood oxygen transport and endothelial dysfunction in patients with arterial hypertension. Clin Physiol Funct Imaging 24 (2004) 205-211
34. Node K., Kitakaze M., Yoshikawa H., Kosaka H., and Hori M. Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension 30 (1997) 405-408
35. Panza J.A., Casino P.R., Kilcoyne C.M., and Quyyumi A.A. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87 (1993) 1468-1474
36. Kelm M. The l-arginine-nitric oxide pathway in hypertension. Curr Hypertens Rep 5 (2003) 80-86
37. Saito Y., Nakao K., Mukoyama M., and Imura H. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 322 (1990) 205
38. Kohno M., Yasunari K., Murakawa K., Yokokawa K., Horio T., Fukui T., et al. Plasma immunoreactive endothelin in essential hypertension. Am J Med 88 (1990) 614-618
39. van der Meer I.M., Iglesias del Sol A., Hak A.E., Bots M.L., Hofman A., and Witteman J.C. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study. Stroke 34 (2003) 2374-2379
40. Magyar M.T., Paragh G., Katona E., Valikovics A., Seres I., Csiba L., et al. Serum cholesterols have a more important role than triglycerides in determining intima-media thickness of the common carotid artery in subjects younger than 55 years of age. J Ultrasound Med 23 (2004) 1161-1169
41. Migdalis I.N., Kalogeropoulou K., Iiopoulou V., Varvarigos N., Karmaniolas K.D., Mortzos G., et al. Progression of carotid atherosclerosis and the role of endothelin in diabetic patients. Res Commun Mol Pathol Pharmacol 108 (2000) 27-37
42. Peppa-Patrikiou M., Scordili M., Antoniou A., Giannaki M., Dracopoulou M., and Dacou-Voutetakis C. Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care 21 (1998) 1004-1007
43. Kozakova M., Buralli S., Palombo C., Bernini G., Moretti A., Favilla S., et al. Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension 41 (2003) 230-236